[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339599-105":59,"doc-detail-339599-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","immunotherapy-based-on-immune-checkpoint-molecules-and-immune-checkpoint-inhibitors-in-gastric-cancer-narrative-review","Immunotherapy Based on Immune Checkpoint Molecules and Immune Checkpoint Inhibitors in Gastric Cancer - Narrative Review","","Gastric cancer advances rapidly and shows high metastatic capacity, combining local invasion, dissemination, colonization at distant sites, and immune evasion. Tumour growth is driven by activation of inhibitory immune-response pathways known as immune checkpoints, including PD-1/PD-L1, CTLA-4, TIGIT, and others. Immune checkpoint molecules regulate innate and adaptive immunity; they are present on immune and tumour cells. This narrative review evaluates immune checkpoint molecules and immune checkpoint inhibitors and summarizes ongoing clinical trials targeting these pathways for gastric cancer treatment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/immunotherapy-based-on-immune-checkpoint-molecules-and-immune-checkpoint-inhibitors-in-gastric-cancer-narrative-review/339599/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/immunotherapy-based-on-immune-checkpoint-molecules-and-immune-checkpoint-inhibitors-in-gastric-cancer-narrative-review/339599.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is gastric cancer considered highly aggressive?","Question",{"text":112,"@type":113},"Gastric cancer progresses quickly to advanced stages and exhibits strong metastatic ability, including local invasion and immune response evasion.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What are immune checkpoints and which pathways are highlighted?",{"text":117,"@type":113},"Immune checkpoints are inhibitory signals that regulate immune responses. The review focuses on PD-1/PD-L1, CTLA-4, TIGIT, and additional checkpoint pathways.",{"name":119,"@type":110,"acceptedAnswer":120},"How do immune checkpoint molecules influence cancer immunotherapy?",{"text":121,"@type":113},"Immune checkpoint molecules modulate innate and adaptive immune responses. Their expression on immune and tumour cells and ligand–receptor engagement can inhibit or stimulate immune cells, shaping therapeutic effects.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339599,1790193572,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Review  \nImmunotherapy Based on Immune Checkpoint Molecules and Immune Checkpoint Inhibitors in Gastric Cancer–Narrative Review  \nAgata Poniewierska-Baran 1,2,3, Karolina Sobolak 4, Paulina Nied´zwiedzka-Rystwej 1,2, Paulina Plewa 4 and Andrzej Pawlik 3, *  \nCitation: Poniewierska-Baran, A.; Sobolak, K.; Nied´zwiedzka-Rystwej, P.; Plewa, P.; Pawlik, A. Immunotherapy Based on Immune Checkpoint Molecules and Immune  \nCheckpoint Inhibitors in Gastric Cancer–Narrative Review. Int. J. Mol. Sci. 2024, 25, 6471. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms25126471](10.3390/ijms25126471)  \nAcademic Editor: Nam Deuk Kim  \nReceived: 30 April 2024  \nRevised: 31 May 2024  \nAccepted: 10 June 2024  \nPublished: 12 June 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Center of Experimental Immunology and Immunobiology of Infectious and Cancer Diseases, University of Szczecin, 71-417 Szczecin, Poland; [agata.poniewierska-baran@usz.edu.pl](agata.poniewierska-baran@usz.edu.pl) (A.P.-B.); [paulina.niedzwiedzka-rystwej@usz.edu.pl](paulina.niedzwiedzka-rystwej@usz.edu.pl) (P.N.-R.)  \n2 Institute of Biology, University of Szczecin, 71-412 Szczecin, Poland  \n3 Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland  \n4 Students Research Club of Immunobiology of Infectious and Cancer Diseases “NEUTROPHIL”, University of Szczecin, 71-417 Szczecin, Poland; [232901@stud.usz.edu.pl](232901@stud.usz.edu.pl) (K.S.); paulina.plewa@op.pl (P.P.)  \n* [Correspondence: pawand@poczta.onet.pl](Correspondence: pawand@poczta.onet.pl)  \nAbstract: Due to its rapid progression to advanced stages and highly metastatic properties, gastric cancer (GC) is one of the most aggressive malignancies and the fourth leading cause of cancer-related deaths worldwide. The metastatic process includes local invasion, metastasis initiation, migration with colonisation at distant sites, and evasion of the immune response. Tumour growth involves the activation of inhibitory signals associated with the immune response, also known as immune checkpoints, including PD-1/PD-L1 (programmed death 1/programmed death ligand 1), CTLA-4 (cytotoxic T cell antigen 4), TIGIT (T cell immunoreceptor with Ig and ITIM domains), and others. Immune checkpoint molecules (ICPMs) are proteins that modulate the innate and adaptive immune responses. While their expression is prominent on immune cells, mainly antigen-presenting cells (APC) and other types of cells, they are also expressed on tumour cells. The engagement of the receptor by the ligand is crucial for inhibiting or stimulating the immune cell, which is an extremely important aspect of cancer immunotherapy. This narrative review explores immunotherapy, focusing on ICPMs and immune checkpoint inhibitors in GC. We also summarise the current clinical trials that are evaluating ICPMs as a target for GC treatment.  \nKeywords: gastric cancer; immunotherapy; immune checkpoint molecules; PD-1; PD-L1; CTLA-4; immune checkpoint inhibitors  \n1. Introduction  \nGastric cancer (GC) is the fourth leading cause of cancer-related deaths and the fifth most prevalent type of cancer worldwide. By 2040, the annual burden of GC is projected to increase to ~1.8 million new cases and ~1.3 million deaths [1] . Most cases are reported in Asia (75%), where it is considered to be a serious health problem. GC occurs most often after the age of 50 years, with approximately three fourth of cases in both sexes occurring in the elderly population (over 65 years of age) . Therefore, the risk of developing GC is correlated with age. GC has a relatively poor prognosis, with a 5-year survival rate of only about 36% accordin","cbCaift3UJv0uWZr","https://ap.wps.com/l/cbCaift3UJv0uWZr","pdf",1398830,14,"English","# Introduction\n## Background and epidemiology of gastric cancer\n## Risk factors and clinical presentation\n# Immune checkpoints and immune checkpoint molecules in gastric cancer\n## Key inhibitory pathways and receptors\n## Role of immune checkpoint engagement in immune regulation\n# Immune checkpoint inhibitors and therapeutic rationale\n## Targeting immune checkpoints in clinical development\n# Clinical trials overview\n## Current studies evaluating ICPMs as targets","[{\"question\":\"Why is gastric cancer considered highly aggressive?\",\"answer\":\"Gastric cancer progresses quickly to advanced stages and exhibits strong metastatic ability, including local invasion and immune response evasion.\"},{\"question\":\"What are immune checkpoints and which pathways are highlighted?\",\"answer\":\"Immune checkpoints are inhibitory signals that regulate immune responses. The review focuses on PD-1/PD-L1, CTLA-4, TIGIT, and additional checkpoint pathways.\"},{\"question\":\"How do immune checkpoint molecules influence cancer immunotherapy?\",\"answer\":\"Immune checkpoint molecules modulate innate and adaptive immune responses. Their expression on immune and tumour cells and ligand–receptor engagement can inhibit or stimulate immune cells, shaping therapeutic effects.\"}]","Immunotherapy Based on Immune Checkpoint Molecules and Immune Checkpoint Inhibitors in Gastric Cancer - Narrative Review | PDF",1790031187,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/90678d5ad2e0598ca416b1fe4b234f8a.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d68302eb74dcf1a63d4e93037d830995.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/91d19957edc90b5bd14da3f9f7618886.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/78d70828fd0c82f174497638edc714c1.webp",980,1385]